STOCK TITAN

X4 Pharmaceuticals, Inc. (XFOR) Free Cash Flow by Year

XFOR

X4 Pharmaceuticals, Inc. recorded an outflow of $85.6M in free cash flow in fiscal year 2025. This represents an increase of 34.8% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters X4 Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$85.6M
YoY +34.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XFOR Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Free Cash Flow-$85.6M+34.8%-$131.2M-35.9%-$96.6M-25.1%-$77.2M-7.9%-$71.5M-18.8%-$60.2M-24.8%-$48.2M-89.7%-$25.4M-17.2%-$21.7M+0.1%-$21.7M

XFOR Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash FlowN/AN/A-$15.5M+53.0%-$27.8M+18.5%-$29.9M+53.3%-$12.4M+63.3%-$33.0M-18.9%-$34.1M+50.4%-$64.0M-33.7%-$33.7M-26.9%-$27.8M-45.3%-$68.8M-256.2%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More X4 Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was X4 Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

X4 Pharmaceuticals, Inc. recorded an outflow of $85.6M in free cash flow in fiscal year 2025.

How fast is X4 Pharmaceuticals, Inc.'s free cash flow growing?

X4 Pharmaceuticals, Inc. (XFOR) free cash flow rose by 34.8% year over year, from -$131.2M to -$85.6M in fiscal year 2025.

How has X4 Pharmaceuticals, Inc.'s free cash flow changed over the years?

Across the 10 fiscal years this page covers, X4 Pharmaceuticals, Inc. (XFOR) free cash flow went from -$21.7M in fiscal year 2016 to -$85.6M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what X4 Pharmaceuticals, Inc. (XFOR) reported on that line in every period on record.